AI Science Tracker
EN

PET and MRI learning classifies prostate lesion risk

Medical University of Vienna; Ludwig Boltzmann Institute Applied Diagnostics · 19 Dec 2020 · medicine

Discovery

PET and MRI learning classifies prostate lesion risk

Source check: Source checked. Not independent scientific confirmation.

Finding: An ensemble of random forests combined PSMA PET and MRI features to classify 121 lesions from 52 surgical prostate-cancer patients as lower or higher risk against whole-mount pathology. Patient-separated repeated internal validation reported AUC 0.86. Additional models explored recurrence and overall risk in smaller subsets. This pilot does not establish biopsy replacement, external performance or clinical benefit.

Technology: Random-forest ensemble

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
An ensemble of nine random forests combines imaging features to classify pathology-defined lesion risk, with patient-level partitioning.
Test and result
Whole-mount pathology reference and repeated Monte Carlo validation that kept all lesions from each patient in one partition.
Limitation / still unknown
External validation and clinical utility remain unestablished; this small surgical cohort, global redundancy filtering and histology-informed lesion localization constrain generalization.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8113201/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary relevant model Methods, Results and limitations; exact primary identity and current primary PubMed correction/retraction relationships checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.